IP Library Granted Patent US 11,209,422
Granted Patent B2
US 11,209,422 · App. 16/138,786 · Granted Dec 28, 2021

Methods and kits for detection of coenzyme Q10

Inventors: Shen Luan (Franklin, MA); Niven Rajin Narain (Cambridge, MA); Rangaprasad Sarangarajan (Boylston, MA); Nikunj Narendra Tanna (Belmont, MA)
Assignee: Berg LLC
G01N33/52G01N27/62G01N30/7233G01N33/82H01J49/0027G01N2458/15G01N2560/00Y10T436/20Y10T436/200833
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,209,422
App. No.
16/138,786
Granted
Dec 28, 2021
Kind
B2
Abstract

The invention provides methods for rapid and quantitative extraction and detection of coenzyme Q10 in a sample readily adaptable to high throughput screening methods. The invention further provides reagents and kits for practicing the methods of the invention.

Claims (14)

1. An isotopically labeled analog of the oxidized form of coenzyme Q10 CoQ10-d6 of the following formula:

2. An isotopically labeled analog of the reduced form of coenzyme Q10 CoQ10H 2 -d6 of the following formula:

3. A mixture for analysis by LC/MS/MS comprising a biological sample and the isotopically labeled analog of claim 1 .

4. The mixture of claim 3 , wherein said biological sample is a bodily fluid.

5. The mixture of claim 4 , wherein said bodily fluid is blood.

6. The mixture of claim 3 , wherein said biological sample is serum.

7. The mixture of claim 3 , wherein said biological sample is plasma.

8. The mixture of claim 3 , wherein said biological sample is a human sample.

9. A mixture for analysis by LC/MS/MS comprising a biological sample and the isotopically labeled analog of claim 2 .

10. The mixture of claim 9 , wherein said biological sample is a bodily fluid.

11. The mixture of claim 10 , wherein said bodily fluid is blood.

12. The mixture of claim 9 , wherein said biological sample is serum.

13. The mixture of claim 9 , wherein said biological sample is plasma.

14. The mixture of claim 9 , wherein said biological sample is a human sample.

Assignments (6)
SECURITY INTEREST Recorded Aug 29, 2025
From: BPGBIO INC.
To: BERG SURVIVOR’S TRUST; BERG, KARA ANN; THLIVERIS, ANDREW T.
Reel/Frame 072805/0303 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 8147825 WAS ADDED PREVIOUSLY RECORDED AT REEL: 70903 FRAME: 693. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Apr 30, 2025
From: BPGBIO INC.
To: PHOENIX GENESIS LLC
Reel/Frame 071285/0001 →
SECURITY INTEREST Recorded Apr 21, 2025
From: BPGBIO INC.
To: PHOENIX GENESIS LLC
Reel/Frame 070903/0693 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2023
From: BERG LLC
To: BPGBIO, INC.
Reel/Frame 063842/0405 →
CHANGE OF NAME Recorded May 10, 2019
From: BERG PHARMA LLC
To: BERG LLC
Reel/Frame 049150/0289 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2019
From: LUAN, SHEN; NARAIN, NIVEN RAJIN; SARANGARAJAN, RANGAPRASAD; TANNA, NIKUNJ NARENDRA
To: BERG PHARMA LLC
Reel/Frame 049008/0554 →